Clinical outcomes associated with albuminuria in central Australia: a cohort study

Autor: Kevin G. Rowley, Alicia J. Jenkins, Kerin O'Dea, Mark Daniel, Rebecca Ritte, Robyn McDermott, Alex Brown, Joanne N Luke, James D. Best, Craig Nelson
Přispěvatelé: Ritte, Rebecca, Luke, Joanne, Nelson, Craig, Brown, Alex, O'Dea, Kerin, Jenkins, Alicia, Best, James D, McDermott, Robyn, Daniel, Mark, Rowley, Kevin
Jazyk: angličtina
Předmět:
Male
Nephrology
Native Hawaiian or Other Pacific Islander
rural and remote health
medicine.medical_treatment
030204 cardiovascular system & hematology
Aboriginal people
0302 clinical medicine
Risk Factors
Rural and remote health
Longitudinal Studies
030212 general & internal medicine
albumin creatinine ratio
risk
Aged
80 and over

education.field_of_study
Middle Aged
Urology & Nephrology
End stage renal disease
3. Good health
Cardiovascular Diseases
Creatinine
Disease Progression
Female
medicine.symptom
Cohort study
Research Article
Risk
Adult
medicine.medical_specialty
Adolescent
Population
Urinalysis
albuminuria
Young Adult
03 medical and health sciences
Predictive Value of Tests
Renal Dialysis
Internal medicine
Diabetes Mellitus
cohort study
medicine
Albuminuria
Humans
Obesity
education
end stage renal disease
Dialysis
Aged
Proportional Hazards Models
Retrospective Studies
Waist-Hip Ratio
business.industry
Australia
Albumin creatinine ratio
Retrospective cohort study
medicine.disease
Kidney Failure
Chronic

business
Kidney disease
Zdroj: BMC Nephrology
ISSN: 1471-2369
DOI: 10.1186/s12882-016-0328-1
Popis: Background Chronic kidney disease (CKD) and end-stage-kidney disease (ESKD) continue to be under-diagnosed and a major burden for Aboriginal communities in central Australia. The aim of this study was to examine the risk of poor clinical outcomes associated with elevated albumin-to-creatinine ratio (ACR) among Aboriginal people in central Australia. Methods Cox proportional hazards models were used to estimate the risk of end stage kidney disease (ESKD), dialysis, CVD (cardiovascular disease) and mortality associated with participants’ baseline albuminuria reading from a 10-year cohort study of Aboriginal people (n = 623) from three communities in central Australia. Predictors of progression of albuminuria were also examined in the context of the Kidney Health Australia (KHA) Risk Matrix. Results A baseline ACR level of ≥3.5 mg/mmol was associated with an almost 10-fold increased risk of ESKD (95%CI 2.07-43.8) and a 15-fold risk of dialysis (95%CI 1.89-121). Albuminuria ≥3.5 mg/mmol was also associated with a borderline 63 % increased risk of CVD (95%CI 0.98-2.71). No significant association was observed with mortality from all-causes or chronic disease. Diabetes and a waist-to-hip ratio ≥0.90 independently predicted a two-fold increased risk of a progression to higher ACR levels. Conclusions A single measure of moderately increased albuminuria was a strong predictor of renal failure in this population. A single spot urine ACR analysis in conjunction with the KHA Risk Matrix may be a useful and efficient strategy to screen for risk of CKD and progression to dialysis in remote communities. A focus on individuals with diabetes and/or central obesity for strategies to avoid increases in albuminuria may also prevent future CKD and CVD complications. Electronic supplementary material The online version of this article (doi:10.1186/s12882-016-0328-1) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE